Patent Intelligence Brief
Know the Pichia expression patent landscape before you commit to a strain.
A structured PDF brief mapping which patents teach expression of your target protein in Pichia pastoris — who owns them, what titer and construct strategies they disclose, and where the evidence is strong vs. needs-verification.
Contact for scope · 3–5 business days · Based on 2,500+ curated patent titer records across 386 publications.
2,580
curated titer records
What you get
1
Patent landscape tableEvery patent teaching expression of your protein in Pichia — publication number, assignee, year, record count, titer range, provenance tier.
2
Assignee concentration analysisWho owns the most patents and records in this landscape. Spot dominant players (e.g. Lonza's promoter portfolio) and white space.
3
Construct strategy summaryWhich promoters (pG1–pG8, pCS1, pGAP, AOX1…), signal peptides (α-MF, native leaders…), and chaperones (GCN4, HAC1, PDI…) the patents teach, ranked by frequency.
4
Titer benchmarkMin / median / max reported titers (mg/L) with sample size, so you can sanity-check your own targets against published precedent.
5
Coverage gaps & verification needsHonest annotation of which patents lack a curated assignee, which records are "needs-verify" provenance, and where a full FTO from a patent attorney is recommended.
Important scope note.
This is a technical intelligence brief, not a legal opinion. It is built from patent EXAMPLE/TABLE titer data, not patent claims text. It does not assess claim scope, validity, enforceability, or freedom-to-operate. Assignee mappings are curated for high-confidence patents; others require external verification. Validate all findings with a qualified patent attorney before making IP decisions.
Request a brief
Tell us your target protein. We'll respond within 1 business day with a scoped quote and turnaround estimate.